OUR PRODUCTS

MOBILE APPS

GENERAL INFO

BIIB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Biogen (BIIB) Earnings Date & Reports

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BIIB is expected to report earnings to fall 29.80% to $3.84 per share on October 22

Q3'25

Est.

$3.84

Q2'25

Beat

by $1.48

Q1'25

Beat

by $0.06

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.31

The last earnings report on July 31 showed earnings per share of $5.47, beating the estimate of $3.99. With 93.24K shares outstanding, the current market capitalization sits at 19.16B.

View a ticker or compare two or three

Compare

BIIB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BIIB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BIIB showed earnings on July 31, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 Binney Street

Phone

+1 617 679-2000

Employees

7570

Web

https://www.biogen.com